Regulation of Nrf2-Mediated Phase II Detoxification and Anti-oxidant Genes

Young-Sam Keum1

  • 1Department of Biochemistry, College of Pharmacy, Dongguk University, Goyang 410-773, Republic of Korea.

Insights

Naturally occurring compounds prevent cancer by activating the Nrf2/ARE pathway, boosting detoxification and antioxidant enzymes. This review details the Keap1/Nrf2 mechanism controlling these vital cellular defenses.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Cellular Defense Mechanisms

Background:

  • Dietary compounds show chemopreventive effects through molecular mechanisms.
  • Nrf2/ARE-dependent gene induction is a key cellular defense against oxidative and xenobiotic stresses.
  • This pathway represents a critical mechanism for cancer chemoprevention.

Purpose of the Study:

  • To review the functional significance of the Keap1/Nrf2 protein module.
  • To discuss its role in regulating ARE-dependent gene expression for phase II detoxification and antioxidant enzymes.
  • To describe the biochemical mechanisms controlling Keap1/Nrf2 protein activity and localization.

Main Methods:

  • Review of existing scientific literature on chemoprevention and the Keap1/Nrf2 pathway.
  • Analysis of molecular and biochemical mechanisms regulating Keap1/Nrf2.
  • Description of signaling pathways, phosphorylation, and ubiquitination involved.

Main Results:

  • The Keap1/Nrf2 protein module is central to regulating the Nrf2/ARE pathway.
  • Intracellular signaling kinases and E3 ligase systems control Keap1/Nrf2 phosphorylation and expression.
  • The nuclear export signal (NES) of Nrf2 governs its nucleocytoplasmic translocation.

Conclusions:

  • The Keap1/Nrf2 pathway is a critical regulator of cellular defense mechanisms.
  • Understanding these molecular interactions is key to developing chemopreventive strategies.
  • Dietary compounds can modulate this pathway to enhance cellular protection.

Related Concept Videos

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
101
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
1.3K
Phase II Reactions: Miscellaneous Conjugation Reactions01:19

Phase II Reactions: Miscellaneous Conjugation Reactions

Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
477
Phase I Oxidative Reactions: Overview01:19

Phase I Oxidative Reactions: Overview

Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
1.0K
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.7K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
11.9K